Physician profile
Patrick J Murray
NPI 1043482516
$4,518.78
in general payments reported to CMS, 2019-2025
11 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $294 · 2021: $269 · 2022: $1,946 · 2023: $715 · 2024: $184 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,788.30 | 2019-2025 | Lens 4k, Na, N/A |
| Seapearl East, INC | $1,325.56 | 2019-2024 | |
| Stryker Corporation | $727.27 | 2019-2025 | Mako, Variax |
| Wright Medical Technology, INC. | $269.23 | 2019 | |
| Heron Therapeutics, INC. | $124.86 | 2021 | |
| Integra Lifesciences Corporation | $90.33 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $86.99 | 2019-2020 | |
| Depuy Synthes Sales INC. | $42.58 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $27.50 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.83 | 2019 | |
| Dynasplint Systems INC. | $16.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.